Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study

INTRODUCTION: The glucagon-like peptide-1 receptor analogue (GLP-1RA) semaglutide is associated with improvements in glycaemia and cardiovascular risk factors in clinical trials. The aim of this study was to examine the real-world impact of semaglutide administered by injection in people with type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, David M., Ruslan, Aliya M., Khan, Rahim, Vijayasingam, Daneeshanan, Iqbal, Fizzah, Shaikh, Ayesha, Lim, Jia, Chudleigh, Richard, Peter, Rajesh, Udiawar, Maneesh, Bain, Stephen C., Stephens, Jeffrey W., Min, Thinzar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872110/
https://www.ncbi.nlm.nih.gov/pubmed/33565043
http://dx.doi.org/10.1007/s13300-021-01015-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872110/
https://www.ncbi.nlm.nih.gov/pubmed/33565043
http://dx.doi.org/10.1007/s13300-021-01015-z

Ejemplares similares